Philadelphia, Pennsylvania — According to state and local economic development sources Anpac Bio Technology, USA plans to build out 7,000 square feet of new space in Philadelphia. The company plans to occupy the new space in Philadelphia, on or about May 1, 2020. According to the company website Anpac Bio’s mission is to save people’s lives by screening out pre-cancer and early stage cancer patients, with a novel, game-changing, simple, effective, and affordable technology to catch most cancer types. After more than 9 years, most of the above goals have been achieved. Anpac Bio’s ground-breaking, award-winning technology has accumulated over 140,000 cases with great results in terms of catching pre-cancer and cancer early with high sensitivity and specificity, and covering over 80% of cancer incidences. Anpac Bio has successfully caught pre-cancer and early stage cancer patients. Anpac Bio US lab obtained CLIA certification, and is generating revenue in Asia. Anpac Bio is saving lives on a weekly basis and making a real-life impact in the fight against cancer.

To learn more about Anpac Bio Technology, USA, visit http://www.anpacbio.com/

Company Contact:
Chris Yu, Chief Executive Officer
https://www.linkedin.com/in/dr-chris-yu-ph-d-86a95513/
408-217-2892

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved